New MRI technique aims to spare healthy lung during cancer radiation

NCT ID NCT05302817

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early-phase trial tested whether a special MRI scan using hyperpolarized xenon gas could help doctors plan radiation therapy for non-small cell lung cancer. The goal was to map which parts of the lung are working well so radiation can avoid them, potentially reducing side effects like breathing trouble. Only 9 patients were enrolled before the study was terminated, so the findings are limited.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
hyperpolarized xenon-129 MRI
What this could lead to
If successful, this imaging technique could help doctors plan radiation therapy to avoid damaging healthy lung tissue, potentially reducing breathing problems and improving quality of life after treatment.
What could go wrong
This was a very small, early-phase trial that was terminated early, so results are limited. The approach may not work for all patients, and inhaling hyperpolarized xenon carries unknown risks in people with severely damaged lungs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.